168 related articles for article (PubMed ID: 22200904)
1. Using an exon microarray to identify a global profile of gene expression and alternative splicing in K562 cells exposed to sodium valproate.
Zhang XZ; Yin AH; Zhu XY; Ding Q; Wang CH; Chen YX
Oncol Rep; 2012 Apr; 27(4):1258-65. PubMed ID: 22200904
[TBL] [Abstract][Full Text] [Related]
2. Analyzing gene expression profile in K562 cells exposed to sodium valproate using microarray combined with the connectivity map database.
Zhang XZ; Yin AH; Lin DJ; Zhu XY; Ding Q; Wang CH; Chen YX
J Biomed Biotechnol; 2012; 2012():654291. PubMed ID: 22701306
[TBL] [Abstract][Full Text] [Related]
3. Differential expression and alternative splicing of cell cycle genes in imatinib-treated K562 cells.
Liu J; Lin J; Huang LF; Huang B; Xu YM; Li J; Wang Y; Zhang J; Yang WM; Min QH; Wang XZ
Tumour Biol; 2015 Sep; 36(10):8127-36. PubMed ID: 25983000
[TBL] [Abstract][Full Text] [Related]
4. Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.
Renshaw J; Orr RM; Walton MI; Te Poele R; Williams RD; Wancewicz EV; Monia BP; Workman P; Pritchard-Jones K
Mol Cancer Ther; 2004 Nov; 3(11):1467-84. PubMed ID: 15542786
[TBL] [Abstract][Full Text] [Related]
5. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro].
Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538
[TBL] [Abstract][Full Text] [Related]
6. [Apoptosis mechanism in human chronic myelogenous leukemia K562 cells induced by tetra-arsenic tetra-sulfide].
Ye QD; Gu LJ; Zhao YX; Zhao JC; Chen WG; Zhang B; Jiang LM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):759-63. PubMed ID: 16277837
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of apoptosis-related genes in imatinib-treated K562 cells identified by exon array analysis.
Liu J; Xiao Y; Xiong HM; Li J; Huang B; Zhang HB; Feng DQ; Chen XM; Wang XZ
Int J Mol Med; 2012 Apr; 29(4):690-8. PubMed ID: 22211240
[TBL] [Abstract][Full Text] [Related]
8. BCR/ABL mRNA targeting small interfering RNA effects on proliferation and apoptosis in chronic myeloid leukemia.
Zhu XS; Lin ZY; Du J; Cao GX; Liu G
Asian Pac J Cancer Prev; 2014; 15(12):4773-80. PubMed ID: 24998540
[TBL] [Abstract][Full Text] [Related]
9. miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.
Farhadi E; Zaker F; Safa M; Rezvani MR
Tumour Biol; 2016 Oct; 37(10):14117-14128. PubMed ID: 27517565
[TBL] [Abstract][Full Text] [Related]
10. Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cells.
Morotti A; Cilloni D; Messa F; Arruga F; Defilippi I; Carturan S; Catalano R; Rosso V; Chiarenza A; Pilatrino C; Guerrasio A; Taulli R; Bracco E; Pautasso M; Baraban D; Gottardi E; Saglio G
Cancer; 2006 Mar; 106(5):1188-96. PubMed ID: 16444746
[TBL] [Abstract][Full Text] [Related]
11. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
Dong L; Jensen RV; De Rienzo A; Gordon GJ; Xu Y; Sugarbaker DJ; Bueno R
BMC Med Genet; 2009 Dec; 10():149. PubMed ID: 20043850
[TBL] [Abstract][Full Text] [Related]
12. Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway.
Xu LX; Li ZH; Tao YF; Li RH; Fang F; Zhao H; Li G; Li YH; Wang J; Feng X; Pan J
J Exp Clin Cancer Res; 2014 Dec; 33(1):108. PubMed ID: 25523932
[TBL] [Abstract][Full Text] [Related]
13. Implementation of exon arrays: alternative splicing during T-cell proliferation as determined by whole genome analysis.
Whistler T; Chiang CF; Lonergan W; Hollier M; Unger ER
BMC Genomics; 2010 Sep; 11():496. PubMed ID: 20840771
[TBL] [Abstract][Full Text] [Related]
14. BCR/ABL-mediated increased expression of multiple known and novel genes that may contribute to the pathogenesis of chronic myelogenous leukemia.
Salesse S; Verfaillie CM
Mol Cancer Ther; 2003 Feb; 2(2):173-82. PubMed ID: 12589034
[TBL] [Abstract][Full Text] [Related]
15. Transcription and splicing regulation in human umbilical vein endothelial cells under hypoxic stress conditions by exon array.
Hang X; Li P; Li Z; Qu W; Yu Y; Li H; Shen Z; Zheng H; Gao Y; Wu Y; Deng M; Sun Z; Zhang C
BMC Genomics; 2009 Mar; 10():126. PubMed ID: 19320972
[TBL] [Abstract][Full Text] [Related]
16. MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR-ABL protein.
Hershkovitz-Rokah O; Modai S; Pasmanik-Chor M; Toren A; Shomron N; Raanani P; Shpilberg O; Granot G
Cancer Lett; 2015 Jan; 356(2 Pt B):597-605. PubMed ID: 25305453
[TBL] [Abstract][Full Text] [Related]
17. Exon-skipping in BCR/ABL is induced by ABL exon 2.
Lichty BD; Kamel-Reid S
Biochem J; 2000 May; 348 Pt 1(Pt 1):63-9. PubMed ID: 10794714
[TBL] [Abstract][Full Text] [Related]
18. Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein.
Karimiani EG; Marriage F; Merritt AJ; Burthem J; Byers RJ; Day PJ
Exp Hematol; 2014 Mar; 42(3):183-191.e5. PubMed ID: 24269846
[TBL] [Abstract][Full Text] [Related]
19. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.
Wang W; Zhang J; Li Y; Yang X; He Y; Li T; Ren F; Zhang J; Lin R
Cancer Lett; 2015 Jan; 356(2 Pt B):791-9. PubMed ID: 25449787
[TBL] [Abstract][Full Text] [Related]
20. Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells.
Ortis F; Naamane N; Flamez D; Ladrière L; Moore F; Cunha DA; Colli ML; Thykjaer T; Thorsen K; Orntoft TF; Eizirik DL
Diabetes; 2010 Feb; 59(2):358-74. PubMed ID: 19934004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
